As investors watch out for new highs in the equities market, many are seeking to capitalize on some of the best growth leaders may turn to ETFs based off Investor’s Business Daily high-conviction picks.
Regular readers of Investor’s Business Daily may be well-acquainted with the publication’s venerable IBD 50, a group of fundamentally sound leading stocks displaying impressive relative strength.
After partnering with Innovator Management, the IBD can now be accessed through an ETF wrapper in the form of the Innovator IBD 50 Fund (NYSEArca: FFTY).
“IBD marries fundamental research with technical research,” Graham Day, V.P. and head of Innovator product development and research, told ETF Trends in a call.
FFTY adheres to the CAN SLIM formula pioneered by IBD founder William J. O’Neil. CAN SLIM combines traits such as a company’s current and annual earnings (rising of course), new, innovative products, leadership in a given industry, increased institutional ownership and other factors.
“The Innovator IBD 50 ETF (FFTY) is a tactical, high conviction portfolio consisting of the 50 top-ranked growth stocks according to Investor’s Business Daily’s CAN SLIM stock selection system,” Bruce Bond, Chief Executive Officer of Innovator Capital Management, said in a note. “We are proud to have partnered again with Investor’s Business Daily expanding our portfolio of listings based upon their robust investment research.”
Innovator has also recently come out with the Innovator IBD ETF Leaders ETF (LDRS), a kind of ETF-of-ETFs that uses proprietary relative strength analysis to select various asset classes that show market-leading relative strength, including foreign and domestic equity and fixed income securities, along with other alternative asset classes.